Table 1.
Parameter | RA patients (n = 8) | AC patients (n = 3) |
Age (years) | 58 (34–69) | 56 (49–68) |
Sex (no. of males/females) | 4/4 | 3/0 |
Disease duration (months) | 60 (4–360) | 2 (1–12) |
Rheumatoid factor | 7 positive; 1 negative | 1 positive; 2 negative |
Tender joint count | 9 (5–15) | 1 (1–2) |
Swollen joint count | 11 (5–19) | 2 (1–23) |
ESR (mm/h) | 46 (25–69) | 38 (28–43) |
Erosive disease | 6 positive; 2 negative | None |
No. of DMARDs | 4.5 (1–5) | 0 |
Leukocytes in SF (109/l) | 6.3 (4.5–7.0) | 4.3 (4.2–4.5) |
CRP (mg/l) | 34 (8–97) | 4 (<3–26) |
Results are medians, with ranges in parentheses. AC, arthritis control; CRP, C-reactive protein in plasma; DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; RA, rheumatoid arthritis; SF, synovial fluid.